Thread Content
In the manufacturing of biopharmaceuticals, injections, and high-purity active pharmaceutical ingredients, the choice of material for the equipment’s contact surfaces has a direct impact on product quality and patient safety. The control of extractables and leachables (referred to as E&L) has become a key focus of scrutiny by international regulatory agencies such as the FDA and EMA. Based on international authoritative literature and experimental data, this article systematically compares the overall performance of three mainstream materials—316L stainless steel, Hastelloy C-276, and tantalum coating—in terms of corrosion resistance, metal ion release, surface treatment, and GMP compliance, providing a scientific reference for pharmaceutical companies in making decisions regarding equipment selection. I. Background: Why zero precipitation is crucial. With the increasingly stringent requirements set by the 2025 edition of the Chinese Pharmacopoeia and ICH Q3 guidelines regarding the control of elemental impurities in the production of active pharmaceutical ingredients and formulations, the materials used in pharmaceutical equipment play a key role; the inner surfaces of such equipment come into direct contact with drugs or intermediates. When the material of the contact surface is not stable enough, metal ions, oxides, or coating components may migrate into the liquid medication, forming 【leachables】. Even trace amounts of metals at the ppb (one part in a billion) level can have a significant impact on the structural stability of biological agents. 1.1 Clear requirements at the regulatory level: U.S. Federal Regulation 21 CFR 211.65 specifies that the contact surfaces of equipment 【must not have any reactive, additive, or adsorptive effects on the ingredients, intermediates, or final products of drugs, so as to avoid altering the safety, properties, content, quality, or purity of those drugs». EU GMP Annex 1 (revised in 2022) also requires that the product-contacting surfaces of equipment used in the production of sterile drugs be smooth, pore-free, and corrosion-resistant. The International Coordination Organization ICH is developing the comprehensive E&L guideline ICH Q3E to further strengthen the requirements for systematic evaluation of the materials used in manufacturing equipment. 1.2 Potential hazards of trace metal leaching A peer-reviewed study published in BioProcess International showed that after being stored at room temperature in 316L stainless steel containers for 14 days, monoclonal antibody drugs (MAbs) exhibited significant migration of iron and manganese ions, as detected by ICP-MS (inductively coupled plasma mass spectrometry). Among them: • Manganese concentration in MAb A sample: it reached 405 ppb on day 7 and increased to 901 ppb on day 14 ； • Manganese concentration in MAb B sample: 384 ppb on day 7, and 920 ppb on day 14 ； • For the samples from the same batch stored in Hastelloy (HLY) or glass containers, both iron and manganese ions were below the detection limit (LoQ < 0.025 ppm). The study also indicates that although no immediate toxicity was observed under short-term heat stress, metal ions induce the generation of free radicals through the Fenton reaction, which may lead to degradation issues such as methionine oxidation in monoclonal antibodies during long-term storage, posing a potential risk to the stability of the drugs. II. 316L Stainless Steel: The Cornerstone of the Industry and Its Limitations. Austenitic 316L stainless steel is the most widely used material in pharmaceutical equipment today. Its composition mainly includes iron (Fe), chromium (Cr, about 16–18%), nickel (Ni, about 10–14%), and molybdenum (Mo, about 2–3%). A low carbon content (C ≤ 0.03%) effectively reduces the risk of intergranular corrosion during welding, enabling it to exhibit good workability and cost-effectiveness in GMP environments. 2.1 Compliance Standards and Surface Requirements: GMP regulations require that the surface roughness (Ra) of the product contact surfaces be ≤ 0.8 µm, in order to prevent microbial residue and cross-contamination. • Mechanical polishing: Can achieve Ra ≤ 0.8 µm, meeting basic GMP requirements ； • Electropolishing: It is possible to further reduce the roughness to Ra ≤ 0.4 µm; with a current density of 0.1–0.3 A/cm², up to 50 µm of metal can be removed from a sulfophosphoric acid bath, resulting in a mirror-like surface ； • Passivation treatment: In accordance with ASTM A967 standards, free iron is removed and the Cr₂O₃ protective film is strengthened by immersing in a 20–25% nitric acid solution at 50–60°C for 30–45 minutes, or using a 4–10% citric acid method ； EU GMP Annex 1 (2022), ASME BPE-2024, and ASTM A380 all specify requirements for this process; passivation must be clearly distinguished from pre-operational rinsing and cannot be substituted for it. 2.2 Formation mechanism and limitations of the passivation film. The corrosion resistance of 316L stems from the Cr₂O₃-rich chromium oxide film that forms naturally on its surface. This protective film can self-repair in aerobic conditions, but it has significant limitations in the following scenarios: • Buffers containing chlorides (such as NaCl solutions): the risk of pitting corrosion increases significantly ； • Strongly acidic or strongly alkaline process fluids: Local corrosion, resulting from the destruction of the oxide film, can develop into irreversible damage ； • High-temperature WFI (Water for Injection) or steam systems: Prolonged use can lead to 【erythema】 (Rouge) contamination, requiring regular acid cleaning maintenance (it is recommended to use a phosphorus/citric acid mixture as a cleaning agent at 80°C for 10 minutes every 3–4 days) ； ICP-MS data confirm that, even in the absence of apparent corrosion, metals such as iron and manganese continue to migrate into the contacting liquid at levels ranging from ppb to ppm. 2.3 Comprehensive evaluation: 316L stainless steel is a standard material in the pharmaceutical industry; with proper electrolytic polishing, passivation, and regular maintenance, it can meet the compliance requirements of most GMP scenarios. However, for products that are highly sensitive to metal ions, such as biologics, monoclonal antibodies, and highly active injections, the risk of precipitation cannot be ignored; it is necessary to further reduce this risk by upgrading the materials or using functional coatings. III. Hastelloy (Hastelloy C-276): A superior choice for highly corrosive environments. Hastelloy is a class of high-performance nickel-based alloys that are based on nickel (Ni), with additional elements such as chromium (Cr), molybdenum (Mo), and tungsten (W). In the pharmaceutical industry, C-276 (containing 57% Ni, 16% Mo, 15% Cr) and C-22 (containing 56% Ni, 22% Cr, 13% Mo) are the most commonly used grades. 3.1 Advantages in corrosion resistance: The corrosion resistance of Hastelloy is significantly better than that of 316L stainless steel, especially in the following environments: • Environments with strong acids and bases (such as hydrochloric acid, sulfuric acid, phosphoric acid at various concentrations): C-276 remains stable in both strongly oxidizing and reducing media ； • Corrosive media containing halide ions (Cl⁻): exhibit significantly superior resistance to pitting and crevice corrosion compared to austenitic stainless steels ； • High-temperature process fluids: The nickel matrix confers excellent high-temperature stability, making them suitable for the synthesis of active pharmaceutical ingredients that require high-temperature reactions ； • Complex formulation systems: Multiple drug active ingredients (APIs) generate corrosive intermediates during chemical reactions, which can be effectively resisted by Hastelloy. 3.2 Comparison data on precipitates based on a comparative study published in BioProcess International: • 316L SS containers: During a 14-day exposure period, ICP-MS detected significant precipitation of iron and manganese ions (manganese reaching 901 ppb) ； • Hastelloy (C-276) containers: Both iron and manganese ions were below the detection limit (LoQ = 0.025 ppm), showing performance comparable to glass containers ； • High-molecular-weight aggregates (%HMW): It was slightly lower in the HLY-exposed group compared to the SS group, and the difference became more pronounced under heat stress. The above data indicate that Hastelloy has a significant advantage in reducing the risk of metal ion precipitation, making it particularly suitable for biological products sensitive to oxidative degradation (such as monoclonal antibodies and protein-based drugs). 3.3 Common Application Scenarios • Reactors for the synthesis of highly corrosive active pharmaceutical ingredients (APIs) ； • CIP (in-line cleaning) system pipelines containing halogens or strong acidic cleaners ； • Storage tanks and mixing tanks for high-purity pharmaceuticals (especially in long-term storage scenarios) ； • Piping systems that require frequent high-temperature sterilization (SIP) and are in contact with highly corrosive media. 3.4 Overall evaluation: Hastelloy is an ideal material choice for scenarios with high corrosion severity by process media. Compared to 316L, its procurement and processing costs are higher, but it offers significant life-cycle economic benefits in terms of reducing maintenance frequency, extending equipment lifespan, and ensuring product purity. IV. Tantalum coating: A cutting-edge technology for achieving 【true zero leaching】. Tantalum (Ta, atomic number 73) is one of the metals with the strongest corrosion resistance among those commonly used in industry today; it has chemical inertness similar to that of glass, as well as excellent biocompatibility. However, the overall cost of tantalum equipment is extremely high; the advent of tantalum coating technologies (especially chemical vapor deposition CVD/CVI) has made its use in pharmaceutical equipment possible. 4.1 Film formation mechanism of titanium coating The surface alloying technique for titanium utilizes the chemical vapor deposition (CVD/CVI) process to uniformly deposit a thin layer of titanium on the surface of substrates such as stainless steel, nickel alloys, and titanium. This tantalum layer possesses the following key properties: • Self-healing capability: Once damaged, the Ta₂O₅ oxide layer can rapidly regenerate on its own in an oxygen-rich environment, continuing to provide protection ； • Extremely wide range of chemical inertness: inert to almost all organic acids, inorganic acids (except hydrofluoric acid and concentrated sulfuric acid at high temperatures), and alkalis ； • No geometric constraints: The CVD process enables uniform deposition regardless of shape, allowing it to be used on complex components such as small-diameter pipes, internal cavities, and valve bodies, without being limited by their geometric shape ； • Biocompatibility: Tantalum is highly inert in the human body and is widely used in surgical implants; its zero toxicity gives it a natural advantage as a material for use in pharmaceutical contact applications. 4.2 Corrosion Resistance and Zero Deposition Behavior The corrosion resistance of tantalum is described in authoritative sources as being “comparable to that of glass” – this qualitative description holds great engineering significance. Specifically, this is manifested as: • Below 300°F (about 149°C), there is no corrosion at all in the presence of hydrochloric acid, sulfuric acid, and nitric acid of various concentrations (up to 98%) ； • Reactors treated with a tantalum coating can maintain a passive state at their contact surfaces, effectively preventing contamination and cross-contamination of the process fluids ； • Tantalum-coated heat exchangers are classified as having \"high cleanliness and zero contamination\" for pharmaceutical and food-grade applications; no corrosion allowance is required, and a thin-walled design can be used to reduce thermal resistance ； • Industry test data show that chromatography column hardware coated with tantalum can increase the service life of metal-sensitive analytes by more than 100 times compared to stainless steel columns (ICP-MS experimental data presented by SilcoTek at the Pittcon conference). 4.3 Applications of titanium coatings • Water for Injection (WFI) systems and high-purity contact components used in the production of sterile active pharmaceutical ingredients ； • Key process stages for biologics (antibodies, proteins, nucleic acid-based drugs) – scenarios with zero tolerance for metal ions ； • High-standard scenarios requiring both strong corrosive acids and bases along with zero leaching ； • Alternatives to glass-lined equipment (overcoming the geometric constraints of glass) ； • API synthesis system containing high-active ingredients (HAPI), to avoid metal-catalyzed degradation. 4.4 Cost considerations and long-term value: The initial investment for a tantalum coating is higher than that of 316L, but significantly lower than that of entire tantalum components. Its long-term value lies in extending the equipment’s service life, reducing the frequency of downtime for maintenance, and avoiding batch failures of products as well as regulatory risks caused by metal precipitation. For high-value biological products, the losses resulting from a single batch recall often far exceed the costs of equipment upgrades. V. Comprehensive Comparison of the Three Materials: The table below provides a systematic comparison of the three materials in terms of corrosion resistance, risk of precipitation, surface standards, compliance requirements, and cost. VI. Key Regulatory Frameworks and Technical Standards: In making decisions regarding the selection of materials for pharmaceutical equipment, it is essential to have a clear understanding of regulatory requirements as a foundation for establishing a compliant system. The following is a summary of the key global regulations and technical standards currently in use: VII. Decision-making framework for material selection In practical engineering applications, material selection should follow a risk-based hierarchical decision-making approach, taking into account factors such as product type, processing conditions, regulatory environment, and economic constraints: 7.1 Situations where 316L stainless steel is preferred • Conventional production equipment for ordinary solid formulations or liquids with low corrosivity ； • Scenarios where the equipment is in contact with liquid for short periods and requires frequent cleaning (such as intermittent liquid preparation operations) ； • Facilities with a comprehensive passivation maintenance plan and regular E&L testing for verification ； • Non-injection product lines with high requirements for cost control. 7.2 Situations where Hastelloy is preferred • Equipment systems with highly corrosive API chemicals or halogen-containing cleaning agents ； • The key storage containers for biologics (proteins, monoclonal antibodies) are required to significantly reduce the risk of metal ion precipitation ； • Key points in the WFI or steam system where strict controls are required to prevent Rouge contamination ； • Production scenarios where the process fluid has a wide pH range (from strong acids to strong bases) or contains high salt concentrations. 7.3 Scenarios where a tantalum coating is preferred • Core contact components in injections and high-purity biological products, requiring an 【almost zero】 precipitation standard ； • New biological agents such as nucleic acid drugs (oligonucleotides, mRNA) and gene therapy products, which are extremely sensitive to trace metals ； • High-end applications that require a replacement glass lining but are constrained by geometric constraints, or those seeking to reduce overall tantalum costs ； • Regulatory reviews require a complete E&L data package, as well as evidence showing that the documentation prepared for the registration application supports a scenario of zero leaching. VIII. Conclusion The selection of materials in contact with pharmaceutical equipment is not merely an issue related to engineering materials science; it is also a core component of the product quality management system and patient safety assurance. With the rapid development of biologics and highly precise drugs, international regulatory authorities are continuously raising the standards for E&L control, and \"zero leaching\" is evolving from an industry ideal to a regulatory reality. Thanks to its mature manufacturing processes and cost-effectiveness, 316L stainless steel will continue to play a fundamental role in most general GMP applications ； Hastelloy exhibits outstanding value in meeting the dual requirements of high corrosion resistance and biocompatibility ； Tantalum coating technology represents the forefront advancement in pharmaceutical equipment toward 【true zero leaching】. When selecting equipment, pharmaceutical companies are advised to base their decisions on the ICH risk assessment framework, taking into account product characteristics, process conditions, and life-cycle costs, in order to develop tailored material strategies. Comprehensive E&L test data should be used to support regulatory submissions. This is not only a requirement for compliance, but also the technical foundation for establishing a professional image in the industry and gaining market trust. Statement: This article is owned by Han Tant Instrumentation. Any reproduction must indicate the source 【Han Tant Instrumentation Pipe and Valve Components】